In Vitro Diagnostics Business Outlook: Volume 1, Issue 19 - Molecular Inherited Disease Testing
A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
-
Untitled Chapter
-
Market Analysis:
-
Overview of Molecular Inherited Disease Testing
-
Market Outlook
-
Company Briefs
-
Myriad Genetic
-
PerkinElmer
-
Regional Market
-
Executive News Briefing
-
Beckton Dickinson Appoints New Supply Chain Officer
-
Meridian Bioscience Agrees to be Acquired
-
Financial Highlights: Agilent, Fulgent Genetics, Mainz Biomed
-
Agilent Q2 ‘22 Growth up 5%; 7% on Core Basis
-
Fulgent Genetics Posts Strong Performance in Core Revenue
-
Mainz Biomed Reports Strong Sales for ColoAlert - Boosting Company Performance
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Partnerships and Collaborations
-
Mergers and Acquisitions
-
Industry Watch
-
COVID-19 Update
-
Australia
-
Broad-based Company Announcements
-
Thermo Fisher Launches New Molecular Respiratory Panel
-
Bio-Techne Launches RNAscope ISH Probe
-
Accelerate Diagnostics Gains CE Mark
-
Mylab Discovery Solutions Launches Combined RT-PCR Test Kit
-
IVDBO - Vol 1. Issue 19.pdf